The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
news-avastin
Monday 11 March 2013
The Scottish Medicines Consortium (SMC) has rejected Avastin® (bevacizumab) in Scotland for women whose platinum-sensitive ovarian cancer has returned after initial drug treatment (recurrent). This decision follows the SMC rejection of Avastin in newly-diagnosed advanced ovarian cancer and means...
News
support-group-default
Friday 8 March 2013
Today's story in the Daily Telegraph reveals how, for some women with ovarian cancer, a simple change in how chemotherapy is delivered could help them live years longer.  Target Ovarian Cancer Head of Research Dr Simon Newman comments: “The results from this clinical study are incredibly promising...
News
Friday 11 January 2013
Following today's story in the Daily Mail regarding new NHS data that shows some hospitals are not using Paclitaxel, a key drug in the treatment of ovarian cancer,  Target Ovarian Cancer Chief Executive Annwen Jones comments: “Paclitaxel, along with Carboplatin, are the two most common drugs used...
News
news-avastin
Tuesday 18 December 2012
Target Ovarian Cancer is very disappointed with the negative draft appraisal of the use of Avastin (bevacizumab) in the treatment of women with newly diagnosed advanced ovarian cancer. Avastin is the first new treatment for ovarian cancer showing promise for this group of women in 20 years and may...

Pages